Companies Related to "Spontaneous Remission Diffuse Large Cell Lymphoma" [Most Relevant Company Matches] RSS

04:51 EDT 22nd May 2019 | BioPortfolio

Here are the most relevant search results for "Spontaneous Remission Diffuse Large Cell Lymphoma" found in our extensive corporate database of over 50,000 company records.

Showing "Spontaneous Remission Diffuse Large Cell Lymphoma" Companies 1–25 of 2,600+

Thursday 16th May 2019

Takara Bio USA, Inc.

Takara Bio USA, Inc. (TBUSA; formerly Clontech Laboratories, Inc.) is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for life sciences research applications, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sampl...

Wednesday 15th May 2019

Socati Corp.

Socati is a leading processor of broad spectrum hemp extracts. The company provides a top-quality and consistent product for a market projected to reach $22 billion by 2022. Leveraging investments in new technologies, Socati engages in large-scale manufacturing and has logistics in place to process increasing amounts of hemp biomass to meet demand. With th...

Tuesday 14th May 2019

Luciole Medical AG

Luciole Medical AG is developing a unique, next-generation platform of brain monitoring sensors to rapidly provide important information allowing the proper diagnostic and monitoring of compromised oxygen supply conditions and complications. The platform also uses a proprietary complex algorithm to analyse large data sets and extract clinically relevant in...

Wednesday 8th May 2019

BioNTech SE

BioNTech SE is Europe’s largest privately-held biopharmaceutical company pioneering the development of precision immunotherapies for individualized treatment of cancer and prevention of infectious diseases. The company combines all building blocks for more precise and individualized immunotherapies under one roof – from diagnostics and drug devel...

Tuesday 7th May 2019

RevCycle+, Inc.

RevCycle+, Inc. is the charge capture and coding business line which encompasses majority of the workforce of its sibling company, T-System. Specializing in emergency department charge capture and coding since 2002, RevCycle+® combines intelligent coding technology with expert services. RevCycle+®’s solutions improve quality and compliance and r...

Wednesday 24th April 2019

Kite, a Gilead Company

Kite, a Gilead Company, is a biopharmaceutical company based in Santa Monica, California. Kite is engaged in the development of innovative cancer immunotherapies. The company is focused on chimeric antigen receptor and T cell receptor engineered cell therapies. For more information on Kite, please visit


Rexgenero is a clinical-stage regenerative medicine company developing innovative cell-based therapies targeting serious diseases with unmet medical needs.

Tuesday 23rd April 2019

HD Medical Inc.

HD Medical, Inc. is a medical device innovator based in California, USA with Offices in Sydney, Australia and Research Labs in Chennai, India. Since 2005 the company has designed and developed medical products for use in screening and early detection of cardiac conditions. The company markets its innovations to medical professionals, large medical institut...

Monday 22nd April 2019

Paragon Biosciences, LLC

Paragon is a life science innovator that invests in, builds, and advises bioscience companies. Our mission is to serve patients living with severe medical conditions which do not yet have adequate treatments. Paragon’s portfolio of independently-run bioscience companies focus on: biopharmaceuticals, AI-enabled life science products, and advanced treat...

Thursday 18th April 2019

Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc., formerly Regenerex, is a late-clinical stage biotechnology company that is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. Talaris ...

Tuesday 16th April 2019

SanBio Group

SanBio is a regenerative medicine company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research, development and clinical trials. Its proprietary cell-based investigational product, SB623, is currently in a Phase 2b clinical trial for treatment of chronic motor deficit resulting from ischemic stroke, a...

ACEA Biosciences, a part of Agilent Technologies

ACEA Biosciences, a part of Agilent Technologies, is a pioneer in the development and commercialization of high-performance cell analysis platforms for life science research. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and NovoCyte® Quanteon flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety p...

Friday 12th April 2019

Benevis LLC

Benevis is a leading dental support organization (“DSO”) providing non-clinical support functions to over 150 dental offices across 17 states and Washington D.C. The Company’s supported practices range from single dental offices that have been serving their community for decades to large multi-location practices serving thousands of patients. Offic...

Tuesday 9th April 2019

xCella Biosciences

xCella is an antibody engineering and drug discovery company based on intellectual property originally developed at Stanford University in the Stanford Photonics Research Center and the laboratory of Dr. Jennifer Cochran in the Stanford Department of Bioengineering. The xPlorationTM platform enables high throughput screening of millions of B cells based on...

Selexis SA and Generium JSC

Selexis SA, a JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 115...

Monday 8th April 2019

Entegris, Inc.

Entegris is the world’s leading materials integrity management company. Our products, services and technologies purify, protect and transport the critical materials that are used to manufacture today’s advanced technological products.From production to consumption, we enable our customer’s success by ensuring that the integrity of their critical materials remains unchanged during transport t...

Thursday 4th April 2019


Inscripta is a gene editing technology company that puts researchers in control by making it easy for them to get all they need for cutting-edge, single cell engineering. These tools include a family of CRISPR enzymes (called MADzymes), custom nucleases for researchers and commercial partners, and a full suite of gene editing tools (instruments, reagents, ...

Wednesday 3rd April 2019

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a novel therapeutic for Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases. The company’s therapeutic, AMX0035, targets the neuroinflammation and nerve cell death that characterize these diseases. AMX0035 is a proprietary combina...

Tuesday 2nd April 2019

QUE Oncology

QUE Oncology, Inc. is a global clinical stage biotechnology company developing drugs for large unmet medical needs. The company’s lead drug program, Q-122 is initially focused on the treatment of hot flashes in breast cancer survivors undergoing hormone therapy. Several clinical studies with Q-122 have shown the drug to be safely administered to over ...

Monday 1st April 2019

PellePharm, Inc.

Founded by world leaders in hedgehog pathway signaling, PellePharm, a BridgeBio Company, is committed to targeting rare, genetic dermatological diseases, including Gorlin Syndrome and High Frequency Basal Cell Carcinoma (HF-BCC), at their source. PellePharm’s mission is to improve the quality of life for those suffering from Gorlin Syndrome and HF-BCC...

Wednesday 27th March 2019

Resolution Bioscience, Inc.

ctDx-Lung is built on Resolution’s patented cell-free DNA NGS analysis platform. The liquid biopsy assay captures and analyzes circulating tumor DNA (ctDNA) for driver mutations in 20 genes associated with NSCLC using Resolution’s proprietary targeted capture NGS chemistry and cloud-based bioinformatics.

Tuesday 26th March 2019

NanoSurface Biomedical

NanoSurface Biomedical is a biotechnology company based in Seattle, WA that develops biomimetic technologies to enhance cell-based assays and accelerate drug development. NanoSurface was founded in 2015.

Monday 25th March 2019


Fusionex is an established multi-award winning data technology provider specializing in Analytics, Big Data, the Internet of Things, Machine Learning and Artificial Intelligence. Its offerings are focused on helping clients capture, store, process, analyze and make sense of vast amounts of structured and unstructured data. Featured on Forbes, Bloomberg, Ga...

InteRNA Genomics

InteRNA Genomics B.V., a subsidiary of InteRNA Technologies B.V. and based in Bilthoven, the Netherlands, offers services and software for processing, analyzing and presenting ultra-high-throughput sequencing data generated by various platforms. InteRNA's proprietary informatics solutions, Intess(TM), convert large sets of raw sequencing data into interpretable formats and integrate this infor...

Thursday 21st March 2019

The Nagourney Cancer Institute

Dr. Robert Nagourney, a board-certified oncologist/hematologist, is the founder and medical laboratory director of the Nagourney Cancer Institute in Long Beach, CA. He has pioneered the use of human tissue studies for individualized treatment selection and spearheaded new drug development using the Ex Vivo Analysis of Programmed Cell Death (EVA/PCD) platfo...

More From BioPortfolio on "Spontaneous Remission Diffuse Large Cell Lymphoma"

Quick Search


Corporate Database Quicklinks